TG THERAPEUTICS INC
TGTXNASDAQ🏆 #935 by market capEarnings Nov 2US Equity
$50.18▲ $0.28 (+0.56%)
Live1h▲ 0.1%
24h▲ 0.6%
7d▲ 0.6%
14d▼ 6.1%
30d▼ 8.8%
1y▲ 85.0%
🏦Market Cap
$7.68B
Small Cap
📈Revenue Growth (YoY)
+87.3%
High Growth
📊Gross Margin
82.4%
High
💵FCF Margin
-0.1%
Thin
⚖️P/S Ratio
9.6x
Elevated
Otter Score
51
Weak
📊
Analyst Ratings
Price
$50.18
Total
13
Raised
0
Lowered
1
Avg PT
$80.50
H / L
$83 / $78
| Institution | Action | Rating | Date |
|---|---|---|---|
B. Riley Securities | Reiterated | Buy | 2026-07-27 |
HC Wainwright & Co. | Reiterated | Buy | 2026-07-13 |
B of A Securities | Reiterated | Underperform | 2026-07-07 |
JP Morgan | Reiterated | Overweight | 2026-02-02 |
Goldman Sachs | Reiterated | Neutral | 2026-01-15 |
Ladenburg Thalmann | Reiterated | Buy | 2024-05-02 |
Jefferies | Reiterated | Buy | 2023-11-01 |
Cantor Fitzgerald | Reiterated | Overweight | 2023-02-07 |
Evercore ISI Group | Reiterated | Outperform | 2023-01-24 |
HC Wainwright& Co. | Reiterated | Buy | 2021-08-01 |
B. Riley FBR | Reiterated | Buy | 2021-02-09 |
H.C. Wainwright | Reiterated | Buy | 2020-01-17 |
Raymond James | Downgraded | Strong Buy → Outperform | 2018-09-25 |
One row per institution, most recent rating